NEW YORK CITY, NY / ACCESS Newswire / February 21, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Oracle Corporation ("Oracle" or the "Company") (NYSE:ORCL).â?¯â?¯ Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged […]
NEW YORK CITY, NY / ACCESS Newswire / February 21, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against agilon health, inc. ("Agilon" or the "Company") (NYSE:AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / February 21, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Inovio Pharmaceuticals, Inc. ("Inovio" or the "Company") (NASDAQ:INO) and certain officers.�� The class action, filed in the United States District Court for the Eastern District of Pennsylvania, and docketed under 26-cv-00803,
NEW YORK CITY, NY / ACCESS Newswire / February 21, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against PayPal Holdings, Inc. ("PayPal" or the "Company") (NASDAQ:PYPL).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / February 21, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Richtech Robotics Inc. ("Richtech" or the "Company") (NASDAQ:RR).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / February 21, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Vistagen Therapeutics, Inc. ("Vistagen" or the "Company") (NASDAQ:VTGN).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / February 21, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Ardent Health, Inc. ("Ardent" or the "Company") (NYSE:ARDT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / February 21, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed on behalf of shareholders of Quantum Biopharma Ltd. ("Quantum" or the "Company") (NASDAQ:QNTM).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who
Washington, D.C., Feb. 21, 2026 (GLOBE NEWSWIRE) — Paradigm Press has recognized James Altucher for his recent presentation and sustained work examining how technological breakthroughs influence the evolution of business, entrepreneurship, and financial systems. The distinction reflects years of research and commentary focused on understanding how innovation progresses from early development into widespread economic force.
James Altucher Named a Leading Technology Expert following Recent Presentation Paradigm Press recognition reflects his role explaining how emerging technologies reshape industries, enterprise growth, and financial direction GlobeNewswire February 21, 2026 Washington, D.C., Feb. 21, 2026 (GLOBE NEWSWIRE) — Paradigm Press has recognized James Altucher for his recent presentation and sustained work examining how technological